The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome. [PDF]
Lee HC, Lin YH.
europepmc +1 more source
Comparison of serum very low-density lipoprotein concentrations during transition in primiparous and multiparous cows. [PDF]
Osada S+3 more
europepmc +1 more source
Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion. [PDF]
Newberry EP+7 more
europepmc +1 more source
Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort. [PDF]
Seehusen KE+11 more
europepmc +1 more source
Inhibitory effect of trans-tiliroside on very low-density lipoprotein secretion in HepG2 cells and mouse liver. [PDF]
Nagatomo A+4 more
europepmc +1 more source
Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes. [PDF]
Hirano T.
europepmc +1 more source
The nature of pre beta (very low density) lipoproteins. [PDF]
Donald S. Fredrickson+2 more
openaire +2 more sources
Very-low-density lipoprotein triglyceride and free fatty acid plasma kinetics in women with high or low brown adipose tissue volume and overweight/obesity. [PDF]
Chondronikola M+8 more
europepmc +1 more source
Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels. [PDF]
Gentile M+14 more
europepmc +1 more source
Very low-density lipoprotein cholesterol is associated with extent and severity of coronary artery disease in patients with type 2 diabetes mellitus. [PDF]
Jia A+5 more
europepmc +1 more source